tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
RESEARCH TOOLSreports

Summit Therapeutics (SMMT) Cash flow

1,873 Followers

Summit Therapeutics Cash Flow

SMMT's free cash flow for Q4 2025 was £-100.16M. For the 2025 fiscal year, SMMT's free cash flow was decreased by £-181.34M and operating cash flow was £-100.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
£ -322.93M£ -142.11M£ -76.76M£ -41.58M£ -72.59M
Investing Cash Flow
£ -174.31M£ -205.34M£ -587.77M£ -624.00K£ -306.00K
Financing Cash Flow
£ 617.53M£ 381.23M£ 86.51M£ 620.24M£ 77.92M
End Cash Position
£ 225.58M£ 105.19M£ 71.42M£ 648.61M£ 71.79M
Free Cash Flow
£ -323.59M£ -142.25M£ -76.89M£ -42.21M£ -72.89M
Currency in GBP

Summit Therapeutics Cash Flow